Here are 14 key notes on orthopedic and spine device companies over the past week.
Anika Therapeutics received CE Mark approval for CINGAL.
ArthroMeda, a developer and marketer of medical devices for patients undergoing joint replacement procedures, raised $1.9 million from four investors.
Bone Therapeutics reported the 12-month efficacy results from the PREOB Phase IIA severe osteoporosis trial and results demonstrate a single administration of PREOB has positive effects on pain and osteoporosis blood markers.
BioPoly received the CE mark for its BioPoly RS Partial Resurfacing Shoulder System.
Carestream showcased its Carestream OnSight 3D Extremity System that uses cone beam CT technology to capture weight-bearing and other types of extremity exams at the 2016 American Academy of Orthopaedic Surgeons Annual Meeting.
InVivo Therapeutics' neuro-spinal scaffold device is designed to reduce paralysis symptoms resulting from acute spinal cord injury and continues to see success with INSPIRE study.
Implanet's spine activity saw growth in 2015, due to pediatric scoliosis market share gains and an increased use of the JAZZ platform for degenerative spinal disorders.
A new study published in the Journal of Neurosurgery: Spine examines the Mobi-C artificial disc from LDR for two-level procedures and found that at five years, the success rate for two-level disc replacement was 61 percent with the Mobi-C disc.
The FDA cleared Renovis Surgical Technologies' new Tesera SC Porous Titanium Cervical Interbody Fusion System.
Smith & Nephew has plans to introduce Blue Belt Technologies' Navio surgical system in India.
SpinalCyte announced the preliminary results of phase II animal studies for spinal disc height improvement.
Stryker debuted its Stryker Challenge at the PGA Tour's Shell Houston Open in Humble, Texas.
X-spine Systems, a wholly owned subsidiary of Xtant Medical, received FDA clearance for the Xspan Laminoplasty Fixation System.
Zimmer Biomet and Stryker are leading the Japanese knee replacement devices market.